Keynote Lecture | Thirty-Year Cardiovascular Outcomes on C-Reactive Protein, LDL Cholesterol and Lipoprotein (a)

Saturday, March 7, 2026

2:15 PM - 2:30 PM EST

Location: International Ballroom Center

Speaker(s)

Paul M. Ridker, MD

Director, Center for Cardiovascular Disease Prevention
Brigham and Womens Hospital
Brookline, Massachusetts, United States

Disclosure(s): Kowa, Novartis, Amarin, Pfizer, Esperion, NovoNordisk, NHLBI, NCI: Grant/Research Support (Ongoing); Novartis, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSL Behring, Janssen, Vivi Biopharm, Glaso Smith Kline, SOCAR, Novo Nordisk, Eli Lilly, new Amsterdam, Boehringer-Ingelheim, Cytokinetics, Nodthera, Tourmaline Bio, Cardio therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Uppton, Bitteroot, Bio, Angiowave and receives compensation for service from Leducq Foundation, Paris FR: Minority shareholder equity positions (Ongoing)

Disclosure(s):

Paul M. Ridker, MD: Kowa, Novartis, Amarin, Pfizer, Esperion, NovoNordisk, NHLBI, NCI: Grant/Research Support (Ongoing); Novartis, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSL Behring, Janssen, Vivi Biopharm, Glaso Smith Kline, SOCAR, Novo Nordisk, Eli Lilly, new Amsterdam, Boehringer-Ingelheim, Cytokinetics, Nodthera, Tourmaline Bio, Cardio therapeutics: Consulting Fees (e.g., advisory boards) (Ongoing); Uppton, Bitteroot, Bio, Angiowave and receives compensation for service from Leducq Foundation, Paris FR: Minority shareholder equity positions (Ongoing)